1067 related articles for article (PubMed ID: 26856717)
1. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
Softic S; Cohen DE; Kahn CR
Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
[TBL] [Abstract][Full Text] [Related]
2. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
[TBL] [Abstract][Full Text] [Related]
3. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
4. Dietary carbohydrates and fatty liver disease: de novo lipogenesis.
Chiu S; Mulligan K; Schwarz JM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):277-282. PubMed ID: 29697539
[TBL] [Abstract][Full Text] [Related]
5. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.
Ter Horst KW; Serlie MJ
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878197
[TBL] [Abstract][Full Text] [Related]
6. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
Jensen T; Abdelmalek MF; Sullivan S; Nadeau KJ; Green M; Roncal C; Nakagawa T; Kuwabara M; Sato Y; Kang DH; Tolan DR; Sanchez-Lozada LG; Rosen HR; Lanaspa MA; Diehl AM; Johnson RJ
J Hepatol; 2018 May; 68(5):1063-1075. PubMed ID: 29408694
[TBL] [Abstract][Full Text] [Related]
7. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
8. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.
Moore JB; Gunn PJ; Fielding BA
Nutrients; 2014 Dec; 6(12):5679-703. PubMed ID: 25514388
[TBL] [Abstract][Full Text] [Related]
9. Fructose and hepatic insulin resistance.
Softic S; Stanhope KL; Boucher J; Divanovic S; Lanaspa MA; Johnson RJ; Kahn CR
Crit Rev Clin Lab Sci; 2020 Aug; 57(5):308-322. PubMed ID: 31935149
[TBL] [Abstract][Full Text] [Related]
10. Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease.
Cohen CC; Li KW; Alazraki AL; Beysen C; Carrier CA; Cleeton RL; Dandan M; Figueroa J; Knight-Scott J; Knott CJ; Newton KP; Nyangau EM; Sirlin CB; Ugalde-Nicalo PA; Welsh JA; Hellerstein MK; Schwimmer JB; Vos MB
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34907907
[TBL] [Abstract][Full Text] [Related]
11. Fructose drives de novo lipogenesis affecting metabolic health.
Geidl-Flueck B; Gerber PA
J Endocrinol; 2023 May; 257(2):. PubMed ID: 36753292
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
[TBL] [Abstract][Full Text] [Related]
13. High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation.
Mock K; Lateef S; Benedito VA; Tou JC
J Nutr Biochem; 2017 Jan; 39():32-39. PubMed ID: 27768909
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.
Basaranoglu M; Basaranoglu G; Bugianesi E
Hepatobiliary Surg Nutr; 2015 Apr; 4(2):109-16. PubMed ID: 26005677
[TBL] [Abstract][Full Text] [Related]
15. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing.
Zeng H; Qin H; Liao M; Zheng E; Luo X; Xiao A; Li Y; Chen L; Wei L; Zhao L; Ruan XZ; Yang P; Chen Y
Mol Metab; 2022 Mar; 57():101428. PubMed ID: 34974159
[TBL] [Abstract][Full Text] [Related]
16. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.
Chung M; Ma J; Patel K; Berger S; Lau J; Lichtenstein AH
Am J Clin Nutr; 2014 Sep; 100(3):833-49. PubMed ID: 25099546
[TBL] [Abstract][Full Text] [Related]
17. Fructose induced KHK-C can increase ER stress independent of its effect on lipogenesis to drive liver disease in diet-induced and genetic models of NAFLD.
Park SH; Helsley RN; Fadhul T; Willoughby JLS; Noetzli L; Tu HC; Solheim MH; Fujisaka S; Pan H; Dreyfuss JM; Bons J; Rose J; King CD; Schilling B; Lusis AJ; Pan C; Gupta M; Kulkarni RN; Fitzgerald K; Kern PA; Divanovic S; Kahn CR; Softic S
Metabolism; 2023 Aug; 145():155591. PubMed ID: 37230214
[TBL] [Abstract][Full Text] [Related]
18. ChREBP-driven DNL and PNPLA3 Expression Induced by Liquid Fructose are Essential in the Production of Fatty Liver and Hypertriglyceridemia in a High-Fat Diet-Fed Rat Model.
Velázquez AM; Bentanachs R; Sala-Vila A; Lázaro I; Rodríguez-Morató J; Sánchez RM; Alegret M; Roglans N; Laguna JC
Mol Nutr Food Res; 2022 Apr; 66(7):e2101115. PubMed ID: 35124887
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic inhibition of lipogenesis for the treatment of NAFLD.
Esler WP; Cohen DE
J Hepatol; 2024 Feb; 80(2):362-377. PubMed ID: 37977245
[TBL] [Abstract][Full Text] [Related]
20. Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease.
Paglialunga S; Dehn CA
Lipids Health Dis; 2016 Sep; 15(1):159. PubMed ID: 27640119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
